OpenEvidence, the AI-powered clinical decision-support platform for doctors, has secured a $1 billion valuation in a Sequoia Capital-led Series A funding round. This marks the company’s first institutional investment, bringing its total capital raised to over $100 million.
With this funding, OpenEvidence is set to scale its AI-driven medical knowledge platform, making critical, evidence-based insights more accessible to healthcare providers.
OpenEvidence is changing how doctors access and apply medical knowledge, providing real-time AI-powered assistance at the point of care.
✅ Trusted by doctors – Used daily by hundreds of thousands of verified physicians across 10,000+ healthcare centers in the U.S.
✅ AI-powered insights – Helps doctors make informed clinical decisions in seconds
✅ Exclusive for medical professionals – Free for verified doctors in the U.S.
✅ Built for doctors, by AI experts – Developed by AI scientists from Harvard and MIT
"As we approach our platform’s two-year anniversary, OpenEvidence is already an essential tool for doctors. With this Series A from Sequoia, we’re just getting started." — Daniel Nadler, Founder of OpenEvidence
A key focus of this funding round is advancing OpenEvidence’s medical AI models.
What’s Next?
🔹 Developing specialized Large Language Models (LLMs) for medicine
🔹 Expanding the AI team with top researchers in oncology, neuroscience, and cardiology
🔹 Scaling AI training to ensure more accurate, real-time insights
"Doctors are overwhelmed with growing caseloads and an explosion of medical knowledge. OpenEvidence is the solution they’ve been waiting for." — Pat Grady, Partner at Sequoia Capital
We send one email a week with the best impact reads, interviews, and tools.
Free. Unsubscribe anytime.
Photo credit: Photo: maxlashcheuski - modified by Causeartist
Photo credit: Turnout: Modified by Causeartist
Founder stories, funding news, and tools — curated for impact builders.
Join 25,000+ Causeartists
Free. Unsubscribe anytime.
